Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.
Table of Contents
- Public-private partnerships critical in fight against infectious diseases
-
- Racing toward the right answers: Treating gram-negative bacterial infections
- Complications common in Spanish children with extrapulmonary TB
- AASLD, IDSA update HCV guidance
- CDC: Number of HPV-associated cancers rises
- CDC's Ebola reports detail key programs, lessons from epidemic
- CRISPR-Cas9 technology shows promise in ID, presents ethical quandary
- Drug trial to eliminate Ebola traces in semen opens in Liberia
- Electronic surveillance identifies vaccine-related health events during MenB outbreak
-
- Experts call for England's National Health Service to fund PrEP
- Increased risk for HIV among gay, bisexual adolescent males
- Labs handling hazardous agents report no accidental transmissions in 2015
- IAS-USA releases new recommendations on ARVs
- Mismatched 2014-2015 flu vaccine more effective than initially reported
- New guideline for HAP, VAP recommends shortened antibiotic therapy
- First female-to-male sexual transmission of Zika reported in New York
- NIH-funded study will monitor US Olympic, Paralympic teams for Zika infection
-
- Obama outlines progress, future of ACA
- One-hour test detects MRSA, CoNS
- PARTNER study: ART prevents HIV transmission among serodiscordant couples
- Women of childbearing age show increased risk for HCV
- Researchers discover Zika virus in female genital tract for first time
- Foreign aid programs effective, should be better funded
- Zika: Path to pathogenicity Scott B. Halstead, MD
- The global yellow fever threat and how to deal with it Donald Kaye, MD, MACP; Jack P. Woodall, PhD; Thomas M Yuill, PhD
-
- FDA approves Viekira XR for HCV genotype 1
- FDA approves Roche’s cobas HPV Test for use with SurePath Preservative Fluid
- FDA delays approval decision for Merck’s bezlotoxumab
- Model suggests sexual transmission accounts for 3% of new Zika cases
- Telementoring program improves HIV practitioners’ confidence, knowledge
- In-house assay effective for monitoring HBV in resource-limited countries
- Primary care intervention does not improve sepsis survivors' mental health QOL
- Electronic monitoring system for hand hygiene reduces MRSA rates
-
- AAP recommends pediatricians provide sex education to patients
- Aboriginal Canadian infants taking Synagis remain at greater risk for RSV
- EV-D68, acute flaccid myelitis linked during 2014 Colorado outbreak
- Maternal immunization protects infants against influenza for 8 weeks
- TB prevention response in US averts up to 319,000 cases from 1995-2014
- Age, presence of toxin B antibodies influence C. difficile recurrence
- ARFI elastography predicts fibrosis in patients with HCV who achieved SVR
- Artificial intelligence identifies bat species that could harbor Ebola
-
- Azithromycin-resistant gonorrhea emerges in US
- Circumcision, ART reduce new HIV infections in rural Ugandan men
- Colistin resistance detected in US for second time
- DAAs may benefit in long term for patients with decompensation
- Demand for new HIV providers will outstrip supply by 2019
- Prisoners share disproportionate HIV, hepatitis, TB burden
- Enteric infections constitute majority of infections in New York City infants
- Experts call for response to antibiotic resistance similar to UNAIDS
-
- Flu vaccination reduces respiratory, CV hospitalizations for patients with diabetes
- HCV increases risk for head, neck cancers
- Head size not always indicative of Zika-related abnormalities
- Infected kidneys suspected in rabies deaths of transplant patients in China
- Maps show US counties with Aedes mosquitoes since 1995
- Mechanical ventilation, MDR organism carriage increases risk for CP-CRE transmission
- Medical tourism to Dominican Republic results in multistate mycobacteria outbreak
- Migratory waterfowl may help spread novel H5N6 viruses in China
-
- Mortality from viral hepatitis increases as other ID-related deaths decrease
- Past dengue exposure may increase potency of Zika infection
- Type 2 diabetes patients exhibit higher rates of antibiotic use, infections
- PrEP can cut new HIV infections by one-third in next decade
- Pyrazinamide, fluoroquinolone resistance varies among TB-burdened countries
- Reducing antibiotics for RTIs yields no increase in bacterial complications
- ‘Super-spreader’ patient infected 82 with MERS at South Korea hospital
- Universal ED screening identifies younger HCV cases
-
- IGNITE2: Eravacycline inferior to levofloxacin, but IV formulation shows promise
- Single IV dose of Dalvance treats ABSSSI in IDUs equally well
- Novel HCV DAAs could be mass-produced under $90 per person
- Four fast-track cities announce 90-90-90 data on HIV/AIDS
- HIV vaccine development continues after promising early data
- Old and new: How MDR-TB treatment requires drugs of all ages Rachel S. Bacher, PharmD; Stephen M. Small, PharmD